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Abstract
We developed an evidence-based continuous quality improvement (CQI) cycle for laboratory 
safety as a method of utilizing survey data to improve safety in a public health laboratory setting.
• Expert Opinion: The CQI cycle begins with the solicitation of laboratory staff input via an 
annual survey addressing potential chemical, physical and radiological hazards associated with 
multiple laboratory activities. The survey collects frequency, severity and exposure data related to 
these activities in the context of the most pathogenic organisms handled at least weekly.
• Gap Analysis: Step 2 of the CQI cycle used survey data to identify areas needing improvement. 
Typically, the traditional two-dimensional risk assessment matrix is used to prioritize mitigations. 
However, we added an additional dimension – frequency of exposure – to create three-dimensional 
risk maps to better inform and communicate risk priorities.
• Mitigation Measures: Step 3 of the CQI cycle was to use these results to develop mitigations. 
This included evaluating the identified risks to determine what risk control measures (elimination, 
substitution, engineering, administrative or PPE) were needed. In the 2016 iteration of the CQI 
cycle described here, all mitigations were based on administrative controls.
• Evaluation and Feedback: The last step of the CQI cycle was to evaluate the inferred effects of 
interventions through subsequent surveys, allowing for qualitative assessment of intervention 
effectiveness while simultaneously restarting the cycle by identifying new hazards.
Here we describe the tools used to drive this CQI cycle, including the survey tool, risk analysis 
method, design of interventions and inference of mitigation effectiveness.
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1. Introduction
Laboratory safety is first, and most importantly, an occupational health concern for the 
estimated 290,988 public health workers in the United States (Beck et al., 2014). However, 
contaminated or infected employees can also transmit occupationally acquired pathogens 
outside the laboratory, making any actual or perceived safety breach in a public health 
laboratory a serious concern (Fleck, 2004; Blaser and Lofgren, 1981; Hawkes, 1979). In 
2014, a series of safety incidents among multiple federal agencies drew extensive national 
media attention to the issue of safety in public health laboratories (McCarthy, 2014). These 
safety failures can erode trust in the public health system (Cohen, 2014), which has the 
potential to decrease compliance with public health agency recommendations (Ward, 2017). 
Therefore, the consequences of laboratory incidents in public health laboratories can be 
severe and widespread, even when occupational health risks are low (Centers for Disease 
Control and Prevention, 2014).
While incidents involving biological hazards are often the focus of laboratory-related safety 
discussions, it is well known that laboratories contain many potential hazards - including 
chemical, physical, and radiological (World Health Organization, 2004; Chosewood and 
Wilson, 2009; Occupational Health and Safety Administration, 2011). Unfortunately, current 
data about laboratory incidents is difficult to obtain as there is not yet a standardized system 
for reporting of laboratory incidents (Chamberlain et al., 2009; Dirnagl et al., 2016; Blaine, 
2012). However, some insight into laboratory incidents can be gained using Bureau of Labor 
statistics, which show that of the incidence rate (2011–2016) of nonfatal occupational 
injuries and illnesses involving days away from work in medical and diagnostic labs is 
100/10,000 full-time workers. Of these 100 illnesses or injuries, the source of 1% were 
directly related to chemicals and chemical products. The other 99% of illnesses and injuries 
came from a variety of potential chemical, physical and biological hazards which underlie 
the Occupational Injury and Illness Classification System 2.01 source categories of 
containers, furniture and fixtures (15%), machinery (5%), parts and materials (8%), persons, 
plants, animals and minerals (26%), structures and surfaces (17%), tools, instruments and 
equipment (4%), vehicles (10%) and other sources (13%). While it is difficult to relate these 
reported source categories with the underlying hazards, the breadth of incident sources does 
make obvious the need for laboratory safety risk assessments to consider all-hazards – not 
just biological. In addition to hazard types, there is a growing body of knowledge about 
various contributors to workplace safety (e.g. the effects of mental workload (Charles and 
Nixon, 2019); the need for leadership training (Gravina et al., 2019); the importance of 
occupational ergonomics (Fasanya and Shofoluwe, 2019) and the effects of worker 
personality on safety behavior (Jong-Hyun et al., 2018), which have not been well-studied in 
the laboratory setting.
While laboratory safety has long been a priority in public health laboratories (Moskowitz, 
1948; Cook, 1961; Fuscaldo et al., 1980), multiple gaps remain between published best 
practices and the actual implementation of these practices in laboratories (Westgard, 2017; 
Herrmann-Werner et al., 2013; Van Noorden, 2013). There are many regulations, guidelines 
and standards relevant to the work performed in laboratories, but strategies for 
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implementation of these guidelines are left to individual laboratories to develop (World 
Health Organization, 2004; Chosewood and Wilson, 2009; Richmond and Nesby-O’Dell, 
2002; Ned-Sykes et al., 2015; 7 CFR Part 331, 9 CFR Part 121, and 42 CFR Part 73 - Select 
Agent Regulations, 2018; International Organization for Standardization, 2017; Miller et al., 
2012; 42 CFR 493, 2018; United States Code, 1988; International Organization for 
Standardization, 2018; International Organization for Standardization, 2003; International 
Organization for Standardization, 2012; 29 USC, 1910, 2018). Laboratory Quality 
Management Systems (LQMS) can provide a framework for document and process controls, 
as well as risk assessment and monitoring procedures to improve laboratory safety (Ahlin 
and Weiss, 2007; Lord, 1990; Nichols, 2011); however, LQMS in public health laboratories 
are frequently focused on patient safety and test result accuracy as opposed to occupational 
health and safety (Allen, 2013; Lippi and Guidi, 2007; Njoroge and Nichols, 2014).
The laboratory managers and staff who develop, document and implement laboratory 
procedures bring their own beliefs, knowledge, education, training, attitudes and experience 
to their work, and this can affect how they identify and interpret laboratory hazards (Buxton 
et al., 2011; Steelman and Alexander, 2016; Senthil et al., 2015). Laboratory risk 
assessments are complex and differ significantly from laboratory to laboratory making a 
standardized risk assessment approach difficult. However, obtaining a measure of worker 
perceptions regarding laboratory safety can improve risk management (Xia et al., 2017; 
Tziaferi et al., 2011). These are compelling reasons why better integration of safety and 
quality management in public health laboratories is needed (Sciacovelli et al., 2007).
To determine a standardized process of assessing and mitigating laboratory risk, we chose to 
develop a standardized, evidence-based continuous quality improvement (CQI) cycle. The 
cycle starts with the solicitation of expert opinion regarding laboratory hazards through an 
annual survey. Next is the gap analysis of the survey data to identify potential laboratory 
hazards and perform risk analysis. Based on the gap analysis, we then design and implement 
targeted mitigation measures. With the subsequent annual survey, the cyclic process ends 
when data is compared with the previous year to infer the effectiveness of the mitigation 
interventions and begins again by identifying new hazards or risks to target. Here we 
describe the development of the survey tool and risk assessment method and the application 
of these tools to design and evaluate evidence-based interventions.
1.1. Significant results summary
• Developed practical tools for use by laboratory staff and safety personnel 
including:
– Annual all-hazards survey tool designed to gather laboratory safety 
data.
♦ Tailored to the highest risk group pathogen handled at least 
weekly
♦ Collected information on severity, probability and exposure 
for biological, chemical, physical and radiological hazards 
associated with equipment and processes performed in the lab.
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– Method for stratifying the risk of microorganisms handled in a BSL-2 
laboratory
– Three-Dimensional Risk Assessment Tool designed for analysis of 
survey data
• Identified laboratory-specific risks for targeted intervention
– Potential underutilization of engineering controls
– Potential underreporting of near-misses
– Potentially low awareness of process hazards
• Measured significant differences in survey responses after interventions
– Staff training increased use of engineering controls
– Increased incident reporting burden may cause lower near-miss 
reporting
– Hazard awareness was increased through presentation of survey results
2. Materials and methods
2.1. CQI stage one - expert opinion
To start the CQI cycle, data is collected from our laboratory staff regarding their perceptions 
related to laboratory safety using a survey, which utilizes a non-random sampling 
methodology that is purposive to assess risk and develop mitigation measures in a specific 
federal public health laboratory. The anonymous survey is offered to all staff in the 
laboratory on an annual basis, but its completion is not mandated. Because the sampling is 
purposive, results from this survey are not generalizable to other laboratories. However, the 
survey tool can be tailored to any laboratory.
2.1.1. Survey development—Reviews of multiple guidelines for laboratory safety 
(World Health Organization, 2004; Chosewood and Wilson, 2009; Miller et al., 2012; 29 
USC, 1910, 2018) were completed to formulate survey questions in the following categories: 
Regulatory Requirements, Biologicals (to identify the highest risk organisms worked with at 
least weekly), Equipment (inclusive of biological, chemical, radiological and physical 
hazards), Process (inclusive of biological, chemical, radiological and physical hazards), 
Mitigation (inclusive of elimination, substitution, engineering controls, administrative 
controls and personal protective equipment (PPE)), Quality Controls, Safety Culture and 
Safety Communications. We chose these categories to organize the survey with a goal 
toward obtaining a comprehensive picture of laboratory staff perceptions related to 
laboratory safety. The full text of the survey can be found in the supplementary information 
Appendix A. The specific focus for each category in the survey follows.
2.1.1.1. Regulatory requirements (Questions 1 and 2).: Question 1 (Q1) elicited data for 
the identification of work that requires external oversight. This included identification of 
work involving recombinant DNA, clinical tests, animals, humans, dual use research of 
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concern or transfer of materials from BSL3 or BSL4 level laboratories. An additional 
question collected self-reported data on compliance with these regulations (Q2).
2.1.1.2. Biologicals (Questions 3 through 12).: To elicit data for evidence-based risk 
assessment of microbiological hazards in the laboratory, we formulated questions to obtain 
self-reported data on work with pathogens (Q3) using two techniques.
2.1.1.2.1. Definition of stratified risks within risk group 2.: Risk Group 2 (RG2) 
microorganisms that have been handled in the laboratory over the last 5 years were 
subdivided into three substrata (High, Moderate, Low) based on a combination of literature 
review and expert opinion. We categorized organisms as high risk (Q4) if they were on the 
Department of Health and Human Services (DHHS) and United States Department of 
Agriculture (USDA) Select Agents and Toxins List (7 CFR Part 331, 9 CFR Part 121, and 42 
CFR Part 73 - Select Agent Regulations, 2018) or have been reported as the confirmed 
source of a laboratory-associated infection or exposure (LAI/E) in relevant reviews of the 
LAI/E scientific literature (Baron and Miller, 2008; Singh, 2009; Wurtz et al., 2016; Silver, 
2015; Miller et al., 1987; Campbell et al., 2015; Sullivan et al., 1978; Pike, 1976; Pike and 
Sulkin, 1951; Vesley and Hartmann, 1988). Microorganisms that have been confirmed as 
foodborne infections (FI) (Powell, 2016) or healthcare-associated infections (HAI) (Magill 
et al., 2014) were categorized as medium risk (Q6). The remainder of the RG2 
microorganisms were categorized as low risk (Q8). The genus name of all microorganisms 
in each substrata category were included in the survey text to aid respondents in answering 
questions about these risk categories.
2.1.1.2.2. Use of skip logic.: Since most public health laboratory staff work with multiple 
pathogens, we designed the survey to use conditional logic to obtain the highest risk 
category microbes (Q4, Q6 and Q8) with which the respondent worked with at least weekly 
(Q5, Q7 and Q9). Additional questions (Q10, Q11, and Q12) provided free-form entry of 
additional pathogens but since these only yielded two responses which were included in the 
low risk category, they were not included separately in this analysis. A flowchart of the 
conditional logic structure is included in the Supplemental Materials Appendix B. This 
allowed the responses of each individual to identify the work to consider when answering 
the remainder of the survey.
2.1.1.3. Equipment (Question 13).: Question 13 asked for responses related to the 
frequency of usage, frequency of error and severity of error for potentially hazardous 
laboratory equipment. This was an all-hazards exercise as each piece of equipment 
potentially represents biological (i.e. aerosol production or difficult to clean), chemical (i.e. 
use of hazardous chemicals or potential for spills) or physical hazards (presence of high 
voltage or pinch points). Responses were used to calculate a risk score using a modification 
of the Severity, Probability and Exposure (SPE) Model (Cram, 2004) as explained in Section 
2.2.1. Three-Dimensional Risk Analysis.
2.1.1.4. Process (Question 17).: Question 17 asked staff about the frequency of 
performance, frequency of error and severity of error for potentially hazardous laboratory 
activities and processes. Each process contains some unique combination of biological, 
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chemical or physical hazards. Responses were used to calculate a risk score as explained in 
Section 2.2.1. Three-Dimensional Risk Analysis.
2.1.1.5. Mitigation (Question 12, 14 and 18).: These questions asked staff about the 
frequency of use of multiple risk controls including administrative controls (e.g., procedures, 
job aids, training), engineering controls (e.g., biosafety cabinets, chemical fume hoods, dead 
air boxes) and Personal Protective Equipment (PPE) (e.g., gloves, lab coat, safety glasses) 
when working with biological agents (Q12), equipment (Q14) and processes (Q18). 
Questions 14 and 18 were not included in our analysis as they were removed from the 2017 
survey since the results did not differ from the results of question 12 in the 2016 survey, 
indicating that they were of little added value.
2.1.1.6. Quality controls (Questions 15, 16 and 19).: These questions obtained data from 
staff regarding the frequency of availability of written protocols (Q15), proportion of these 
protocols under document control (Q16) and frequency of adherence to these protocols 
(Q19).
2.1.1.7. Safety Culture (Questions 20, 21 and 22).: These questions obtained data from 
staff regarding the frequency of occurrence of safety culture-related issues in the laboratory 
(Q20), the frequency of notification of incidents and near misses by scenario (Q21) and the 
perceived priority of safety at various institutional management levels (Q22).
2.1.2. Safety survey reliability and validity
2.1.2.1. Content validity.: The content validity of the survey was assessed by a team of 
six subject matter experts (SME) which included non-supervisory laboratory scientists with 
additional expertise in safety and quality, as well as supervisory laboratory scientists with 
experience in managing both laboratory quality and safety. As a group, the education level 
of the SME was 67% PhD and 33% MS with general laboratory experience ranging from 7 
years to over 30 years. The group met multiple times to discuss what should be measured by 
the survey and then each SME reviewed draft survey question and answer sets through three 
iterations to finalize the survey. Lastly, each SME took the online survey in its final form as 
a small pilot to address any remaining issues before release of the survey in 2016.
2.1.2.2. Internal consistency reliability (coefficient alpha).: The internal consistency 
reliability (coefficient alpha) of the survey and the Cronbach’s alpha for each of the scales 
used in the survey was determined using IBM SPSS Statistical Software Version 24 (IBM, 
California). Ideally, the Cronbach’s alpha should be no less than 0.70 and no more than 0.90 
indicating that the scales used are reliable but not redundant (Streiner, 2003). Table 1 lists 
the internal reliability of the scales used in this survey.
2.1.3. Safety survey administration—The 2016 laboratory safety survey contained 
33 questions and was sent to 36 laboratory staff using an anonymous online survey through 
the SurveyMonkey® platform. In 2017, the survey was 31 questions and was sent to 54 
laboratory staff. The respondents were given two weeks to complete the survey, which took 
an average of 16 min to complete (n = 83). In May 2016, 34 staff responded (Response Rate 
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= 94%) while in August 2017, 49 staff responded (Response Rate = 91%). In accordance 
with the Paperwork Reduction Act, no more than 9 non-federal employees were surveyed in 
either year.
2.1.4. Demographic questionnaire—To define the sample population in more detail 
without compromising the anonymity of the laboratory safety survey, we administered a 
separate questionnaire to collect demographic information about our staff in-between the 
2016 and 2017 safety surveys. Respondents answered questions about their age category, 
education and experience. The demographics questionnaire was sent in March of 2017 (10 
months after the 2016 survey and 2 months prior to the 2017 survey) using an anonymous 
online survey through the SurveyMonkey® platform. It was sent to 40 laboratory personnel 
of which 36 responded (Response Rate = 90%). In accordance with the Paperwork 
Reduction Act, no more than 9 non-federal employees were surveyed. The full text of the 
demographic survey is in the supplementary information Appendix C.
2.2. CQI stage two - gap analysis
Once the survey data was collected, the next step was to perform a gap analysis. This 
analysis included reviewing the responses to all survey questions with a team of SMEs to 
identify areas for improvement, performing a three-dimensional risk analysis to identify 
areas of higher relative risk among equipment and processes, and reviewing the most current 
biosafety guidance and scientific literature. Gap analysis results (i.e. risk maps and areas 
identified for improvement) were reviewed by laboratory leadership for awareness and 
adjustment if needed.
2.2.1. Three-dimensional risk analysis—To standardize the approach to prioritizing 
interventions and to maintain the usability of this survey as a practical tool with which to 
improve laboratory safety in a public health laboratory, a method was needed to perform risk 
analyses using survey data. Our goal in this effort was to establish a reproducible method for 
analyzing survey results to prioritize safety interventions. In addition, we wanted a method 
that would be straightforward to perform, provide semi-quantitative results for trend 
analysis, and provide an easily interpreted output (a risk map) for use in prioritizing safety 
interventions. To expand the granularity of the more traditional two-dimensional risk matrix, 
we chose to utilize the Severity, Probability and Exposure (SPE) Model of risk assessment 
and requested that respondents provide their estimation of:
• Severity (s) - How likely it is that an error in equipment usage or process 
performance would lead to injury or exposure.
• Probability of Error (p) - How likely it is for an error to occur while using a 
specific piece of equipment or performing a specific process.
• Exposure (e) - How often a piece of equipment is used or a process is 
performed.
The scale used for perceived probability of error (p) and severity (s) was weighted as 
follows: Highly Likely (75–100%) = 5; Moderately Likely (50–74%) = 4; Somewhat Likely 
(25–49%) = 3, Not Likely (1–24%) = 2 and Not Used (0%) = 1. Exposure (e) was weighted 
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as follows: Daily = 4, Weekly = 3, Monthly = 2 and Yearly = 1. These weights are designed 
to provide a maximum risk score of 100 for ease of comparison and ranking of risk scores 
for prioritizing planning interventions. We then applied this model to various pieces of 
laboratory equipment (n = 25) and multiple laboratory processes (n = 14). We calculated the 
mean of all responses for each variable ((e), (p)and (s)) for each activity or instrument and 
the variables were plugged into the following equation:
Relative Risk = Severity (s) × Probability (p) × Exposure (e)
This method allowed all data to be analyzed in a standardized manner and provides a 
method by which laboratory risks can be compared and prioritized. Risk scores of 80–100 
are considered critical, 60–79 very high, 40–59 high, 20–39 moderate and 1–19 low and are 
graphed as radar maps for ease of risk visualization.
2.3. CQI stage three – mitigation measures
Safety staff and laboratory scientists reviewed and discussed the biological, chemical and 
physical hazards identified during the gap analysis to determine if it was possible to 
eliminate, substitute or isolate the hazards. Engineering controls, administrative controls and 
PPE requirements were also considered and a list of suggested mitigations was prepared. 
The suggestions from safety staff were discussed with additional laboratory staff to 
determine the best mitigation to implement.
2.4. CQI stage four – evaluation and feedback
The final stage of the CQI cycle in 2016 was to present the results of this process to the 
laboratory staff and solicit feedback on the survey and the process. However, in 2017, we 
presented results, solicited feedback and compared the survey data from 2016 and 2017 to 
analyze the efficacy of the 2016 mitigation measures.
2.4.1. Efficacy analysis—We used two-tailed, two sample equal variance t-tests to 
compare 2016 and 2017 survey data to detect significant differences (p < 0.05) in responses 
from one year to another. Because the sample was non-random and the data was 
observational in nature, we cannot prove causality and can only infer that the interventions 
were the cause of changes in survey responses.
3. Results
3.1. Demographics
To describe the sample population while maintaining respondent anonymity, we collected 
demographic data in a separate survey presented in Table 2. These demographics were 
collected in March of 2017 (10 months after the 2016 survey and 2 months prior to the 2017 
survey) and therefore the demographics are most representative of the population sampled in 
2017. The average respondent (see bolded categories) was a non-supervisory laboratory 
employee; 25–34 years of age with a Master’s-level degree and 6–10 years of overall 
laboratory experience with 1–3 years in a federal public health laboratory. All respondents 
reported being vaccinated for Hepatitis B and 77% of respondents have never been injured in 
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a laboratory incident in any setting. Responses to the demographic questionnaire are 
presented as both total respondents and percent of sample population for each category.
3.2. Regulatory requirements (Questions 1 and 2)
Our laboratory functions in the past have included projects involving clinical testing, 
recombinant DNA research, dual use research of concern, human subjects research, animal 
research and transfer of materials from high-containment laboratories. Each of these 
functions require oversight from outside our laboratory. To gauge awareness of the 
requirements for external oversight, respondents were asked to identify which regulatory 
requirements were relevant to their work. There were no statistically significant changes 
from 2016 to 2017 in either the percent of staff doing work that requires external oversight, 
or in self-reported compliance using a two-tailed, two sample equal variance t-test.
Fig. 1 illustrates that the highest percentage of our staff (38% in 2016 and 50% in 2017) 
perform clinical laboratory testing that is overseen by the Centers for Medicare & Medicaid 
Services through the Clinical Laboratory Improvement Amendments (CLIA) regulations 
(United States Code, 1988). A lower percentage of staff work on recombinant DNA research 
(13% in 2016 and 9% in 2017), which is overseen by the Institutional Biosafety Committee 
(IBC) as required by the NIH Guidelines (Federal Register, 2016). This was followed by 
some staff performing work involving dual use research of concern (9% in 2016 and 13% in 
2017) which is overseen by the Institutional Biosecurity Board (IBB) in accordance with the 
United States Government Policy for Institutional Oversight of Life Sciences Dual Use 
Research of Concern (Federal Register, 2014) and work involving human subjects research 
(6% in 2016 and 9% in 2017) which is overseen by the Institutional Review Board (IRB) in 
accordance with the Protection of Human Subjects (Common Rule) (Code of Federal 
Regulations, 2018). The least number of staff reported that they performed work related to 
the transfer of infectious materials out of high containment laboratories (0% in 2016 and 3% 
in 2017) overseen by the Laboratory Safety Review Board (LSRB) as per institutional policy 
or animal research work (6% in 2016 and 0% in 2017) which is overseen by the Institutional 
Animal Care and Use Committee (IACUC) in accordance with the Animal Welfare Act 
(Code, U.S., 1966).
3.3. Handling of microorganisms (Questions 3 through 12)
Staff were also asked a series of questions about RG2 microorganisms they handle in the 
laboratory and the frequency with which they worked with those microorganisms. As 
described in the methods section, the RG2 organisms were arranged into three substrata: 
High (select agents and known etiologic agents of LAI), Moderate (etiologic agents of FI 
and HAI) and Low (remaining organisms). Results reported in Fig. 2 show that while 12 
(2016) and 17 (2017) persons work with high risk organisms, only a small portion of those 
staff work with these organisms at least weekly (3 and 4 in 2016 and 2017, respectively). 
Moderate risk organisms were handled by 21 (2016) and 27 (2017) staff and almost all 21 
(2016) and 23 (2017) work with those pathogens at least weekly. Low risk organisms were 
handled by 2 and 3 staff in 2016 and 2017, respectively at least weekly. There were no 
statistically significant changes in the percent of staff self-reporting at least weekly work 
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with any risk group of pathogens from one year to another using a two-tailed, two-sample 
equal variance t-test.
3.4. Equipment (Question 13)
Respondents were given a list of 25 types of equipment and were asked to identify the 
frequency at which they used that type of equipment. In addition, they were asked to 
categorize the likelihood of an error occurring and the likelihood of that error leading to an 
injury or exposure. The responses were weighted and calculated as detailed in the Section 
2.2.1. Three-Dimensional Risk Analysis. Results are reported as single and combined risk 
maps using relative risk scores in Fig. 3. The top five perceived risks in 2016 (Fig. 3A) were 
1. Freezers, 2. Waterbaths, 3. Electrical, 4. Needles and 5. Heat. In 2017 (Fig. 3B) they were 
1. Machinery, 2. Compressed Gas, 3. Glass, 4. Electrical and 5. Needles. Further analysis 
demonstrated that the largest increases in perceived risk involved autoclaves (Fig. 3C). The 
risk map for autoclaves illustrated that the increased perceived risk was due to an increase in 
both the reported frequency of usage and frequency of error (Fig. 3D).
3.5. Process (Question 17)
Respondents were given a list of 14 laboratory processes and were asked to identify the 
frequency at which they performed those processes. In addition, they were asked to rank the 
likelihood of an error occurring and the likelihood of that error leading to an injury or 
exposure. The responses were weighted and scored as detailed in the Section 2.2.1. Three-
Dimensional Risk Analysis. Results are reported as single and combined risk maps using 
relative risk scores in Fig. 4. The top five perceived risks in 2016 (Fig. 4A) were 1. 
Explosion, 2. Repetitive Motion, 3. Spills, 4. > 500 ml Cultures and 5. Aerosol. In 2017 
(Fig. 4B) they were 1. Spills, 2. Repetitive Motion, 3. Explosion, 4. Aerosol and 5. 
Biological Inactivation. Further analysis demonstrated that the largest increases in perceived 
risk involved biological inactivation (Fig. 4C). The risk map for biological inactivation 
illustrated that the increased perceived risk was due to an increase in both the reported 
frequency of usage and severity (Fig. 4D).
3.6. Mitigation (Question 12, 14 and 18)
Respondents were asked to indicate the different mitigation strategies they use to control risk 
in the laboratory. Fig. 5 presents the self-reported data showing that in 2016, 96% of staff 
used administrative controls (e.g. training, procedures) while only 83% used engineering 
controls. For PPE, 100% of staff used body and hand PPE but only 31% used eye PPE. All 
respondents (100%) had been vaccinated previously for Hepatitis B. In 2017, 100% of staff 
used administrative and engineering controls. PPE use for body and hands remained at 100% 
while eye PPE usage increased to 97%. All respondents (100%) again reported that they had 
been previously vaccinated for Hepatitis B. Increases in the use of engineering controls (e.g. 
biosafety cabinet, chemical fume hood) and eye and face PPE were significant by two-tailed, 
two-sample equal variance t-test (p < 0.05). Respiratory protection is not necessary for most 
of our procedures and the percentage of use remained essentially the same from 2016 (37%) 
to 2017 (40%).
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3.7. LQMS indicators (Questions 15, 16 and 19)
Respondents were asked to gauge the frequency at which: (1) their work processes are 
documented in written protocols, (2) these protocols are in a document control system and 
(3) staff members are adhering to these protocols. Allowable answers were Always (100%); 
Mostly (60–99%); About half of the time (40–59%); Seldom (1–39%) and Never (< 1%). As 
shown in Fig. 6, the median response in 2016 corresponded to work processes always being 
documented and these protocols mostly being in a document control system. Responses also 
indicated that staff mostly adhered to the protocols. In 2017, the only change was a decrease 
in the number of processes that are documented from always to mostly but there were no 
statistically significant changes by two-tailed, two-sample equal variance t-test.
3.8. Safety culture (Questions 20, 21 and 22)
Respondents were asked to categorize the frequency of occurrence of unsafe behaviors 
(disorganized work spaces, inattention, misuse of PPE, non-aseptic practices, lack of 
foresight, intentional risk taking, failure to report incidents) and workplace issues (rushed 
staff, facility issues, lack of resources, equipment issues, lack of administrative controls) that 
could contribute to the probability of a safety incident (data not shown). Allowable answers 
were “Daily, Weekly, Monthly or Yearly”. None of the median responses corresponded to 
“Daily” or “Weekly” Disorganized work spaces and rushed staff had median responses that 
corresponded to “Monthly” for both 2016 and 2017. The median response for all other 
unsafe behaviors or workplace issues corresponded to “Yearly”.
We also elicited opinions on the perceived priority of safety at various institutional 
management levels. Allowable answers included “Safety is a top priority; Safety is low 
priority; Safety is not considered; or Who is this group?”. The results were aggregated into 
levels corresponding to non-supervising staff (Level 1) through the various levels of 
supervisory management (Level 2, 3, 4 and 5). For all levels, the median response indicated 
that safety is a top priority (data not shown). There were no significant changes from 2016 to 
2017 by two-tailed, two-sample equal variance t-test for either of these questions.
Lastly, we asked for staff perspectives about how frequently they would expect that various 
incidents would be reported (Absolutely would report (100%); Most likely (70–99%); It 
could go either way (30–69%); Doubtful (1–29%); Would not report (0%)). For both 2016 
and 2017, the median response corresponded to absolutely would report for any probable 
exposure, possible exposure, release or a major injury. In 2016, respondents indicated that 
they absolutely would report a minor injury but this value dropped to most likely would 
report in 2017. For near misses, both 2016 and 2017 median responses corresponded to “It 
could go either way”. Only the median responses for minor injury reporting were 
significantly decreased (p > 0.05) from 2016 to 2017 by two-tailed, two-sample equal 
variance t-test (Fig. 7).
4. Discussion
Designing an effective laboratory safety program requires data to formulate safety 
interventions that are evidence-based (Cote et al., 2016; Yarahmadi et al., 2016; Smith and 
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Morrato, 2014; Kimman et al., 2008; Birnbaum et al., 2016), but data on laboratory safety 
are limited in various ways. Limitations of published safety data include only being relevant 
to a specific pathogen (Leunda et al., 2013; Tyshenko et al., 2011; Rozell, 2015; Wagar, 
2016; Li et al., 2012; Pedrosa and Cardoso, 2011; Le Duc and Franz, 2012), a single type of 
laboratory (Shurtleff et al., 2012; Dickmann et al., 2015; Elduma, 2012; Higgins et al., 2013) 
or a single laboratory process (Ahlin and Weiss, 2007; Burke, 1993; Serafini et al., 2016; 
Wedum, 1964; Gillespie and Gibbons, 1975; Nimunkar et al., 2017). These lessons learned 
are difficult to apply in public health laboratories due to the complexity of working with a 
large number of microorganisms and performing a breadth of testing services using a variety 
of laboratory equipment and processes while fully complying with numerous standards, 
regulations and guidelines. More comprehensive and standardized strategies are needed to 
effectively integrate evidence-based safety with quality management systems in public 
health laboratories (Pedrosa and Cardoso, 2011; Salerno and Gaudioso, 2015; Westgard, 
2013; Person, 2013; Jairaman et al., 2017; Janssens, 2014; Lentz et al., 2015). We have 
presented results that incorporated the expert opinion of our laboratory staff to address risk 
and create a laboratory safety-specific continuous improvement cycle to inform laboratory 
safety interventions.
We chose to begin the CQI cycle by collecting expert opinions about laboratory-specific 
hazards through a survey of staff members for two reasons. First, it is the laboratory staff 
who have the most expertise and experience in laboratory activities and the safety in the 
laboratory ultimately rests with them. Second, understanding how our staff perceive risks is 
critical to implementing and maintaining effective laboratory safety programs (Xu et al., 
2014; Robertson et al., 2015; Kleiner et al., 2015; Schulte et al., 2012; Chung et al., 2015). 
The survey was designed to improve our understanding of risk in the laboratory setting. 
First, although all microorganisms are handled in our biosafety level 2 (BSL2) laboratory 
(Charles and Nixon, 2019) and are RG2 agents, some of our microorganisms are considered 
to be more pathogenic or transmissible than other RG2 microorganisms. While biosafety 
levels are invaluable benchmarks for basic laboratory safety (World Health Organization., 
2004; Chosewood and Wilson, 2009), they are, by necessity, very general and should mark 
the beginning of a more rigorous assessment of microorganism risk (Gravina et al., 2019; 
Buxton et al., 2011). To seek more precision in how we managed biological risk, we sought 
to stratify our RG2 microorganisms into high, moderate and low risk categories. Second, we 
also utilized skip logic in the survey to ascertain the most pathogenic microorganisms that 
each staff member works with at least weekly. This enabled us to obtain frequency and 
severity data to better define our microorganism-associated risks and provided the biological 
context for respondents to use when responding to the remainder of the survey (Fig. 2).
The CQI cycle continued with a gap analysis to identify and prioritize risks. We chose a 
three-dimensional risk analysis method using data on the probability of error, severity of 
error and likelihood of exposure, as opposed to the traditional two-dimensional matrices 
(probability and severity of error) (Manuele, 2001). This provided a method to identify risks 
at a more granular level and to better understand how staff in our laboratories perceive 
equipment (Fig. 3) and process (Fig. 4) risks. The output of this method is a risk map that 
offers a graphical presentation of risk by probability, severity and exposure. Graphical risk 
communications have been shown to contribute to successful safety interventions (Severtson 
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and Henriques, 2009). This approach to hazard identification, risk analysis and risk 
communication was successful in raising awareness of laboratory safety amongst our staff 
and engaging them in these processes.
Understanding and prioritizing the risks leads to the next step in the CQI cycle – the design 
of mitigation measures. For example, in 2016, we identified the following as areas for 
targeted intervention:
• Potential underutilization of engineering controls (Fig. 5)
• Potential underreporting of near-misses (Fig. 7)
• Potentially low awareness of process hazards (Fig. 4)
To address engineering controls, we performed refresher training for all staff on biosafety 
cabinet usage. We also developed and implemented a laboratory-specific risk assessment 
procedure, which was used to expand and tailor the safety section of multiple laboratory 
procedures to raise awareness of hazards specific to those activities. Lastly, we implemented 
a new laboratory incident response and reporting notification program to address near miss 
reporting.
To close out the CQI cycle, we elected to utilize the data from the subsequent annual survey 
to evaluate the effects of the interventions. In 2017, engineering control use (Fig. 5) and 
process awareness was increased (Fig. 4) which was consistent with successful interventions 
in this area. In both cases, institutional efforts in laboratory safety and risk assessment 
training occurred in the same timeframe and most likely amplified the effectiveness of our 
efforts. Interestingly, responses indicated that staff were less likely to report minor injuries in 
2017 (Fig. 6) despite issuance of both institutional and laboratory-specific policies regarding 
incident response and notification. It has been shown in other laboratory settings that 
additional restrictions and requirements on laboratory activities are not always beneficial 
(Shurtleff et al., 2012) so it is important to determine if the incident notification intervention 
– as designed – should be reevaluated. The collection of data on an annual basis also allows 
evaluation of interventions that are generated from outside this process. For example, in 
2017 we observed a significant increase in eye PPE (Fig. 5) due most likely to a new 
institutional policy requiring the use of safety glasses in all laboratories. Evaluating the 
efficacy of interventions using data from a subsequent survey is an inferential process. The 
data we collect is non-random and any changes that occur after an intervention may not 
necessarily be caused by the intervention. However, the evaluation of data on an annual basis 
allows us to infer how perceptions of laboratory safety are changing which restarts the CQI 
cycle by identifying new hazards and risks to address.
We have centralized requests for IBB, IBC, LSRB, IACUC and IRB protocol approvals 
which allows us to compare the data we collected about external oversight to what our 
records show indicating that staff are aware of these oversight requirements (Fig. 1). We also 
collected data consistent with our current understanding of barriers to safety. For example, a 
major barrier to staff compliance with laboratory safety directives is lack of time (Shakoor et 
al., 2016). Our data is consistent with this as rushed laboratory staff, along with disorganized 
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laboratory areas and facility issues, were the most frequently reported workplace conditions 
that could potentially lead to a safety incident.
There are obvious limitations to this method of data collection and analysis. We observed a 
potential for self-reporting bias as 100% of staff reported using administrative controls, 
while also reporting that only 60–99% of other staff members were doing the same. Future 
surveys will use a new scale with smaller ranges for this answer to try to detect the extent of 
this bias (i.e. was the reported 60–99% of staff who use administrative controls actually 
closer to 60% or closer to 99%). In addition, inferring efficacy of interventions is also 
limited as there is no way to prove that any change in responses is due to a targeted 
intervention as opposed to be due to changes in the workforce, laboratory goals or external 
directives.
Successful interventions to improve safety include training (Coelho and García Díez, 2015; 
Olson et al., 2009; Pallozzi et al., 2003) and the establishment of core competencies for 
biosafety (Chamberlain et al., 2009). We utilized training interventions with success in 
significantly increasing the reported use of engineering controls (Fig. 5) and raising the level 
of awareness regarding laboratory process risks among laboratory staff (Fig. 4). We also 
implemented a knowledge transfer assessment after safety training, which allowed additional 
trainings and interventions to identify and address gaps in trainer expertise as well as staff 
knowledge. It is vital that public health laboratories establish and maintain high safety 
standards. However, the diversity and complexity of the work performed in public health 
laboratories makes it difficult to maintain, monitor and continuously improve laboratory 
safety management. The tools and observations described here can be used to enhance 
engagement of expert staff and provide a means of generating practical evidence-based 
safety interventions within a Quality Management framework.
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Fig. 1. 
Work requiring external oversight. Total percent of staff who self-report that their work 
requires external oversight by Clinical Laboratory Improvement Amendments (CLIA), 
Institutional Biosafety Committee (IBC), Institutional Biosecurity Board (IBB), Institutional 
Review Board (IRB), Institutional Animal Care and Use Committee (IACUC), and 
Laboratory Safety Review Board (LSRB) for 2016 (black) and 2017 (grey).
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Fig. 2. 
Work with pathogens. Total percent of staff self-reporting work with high (black columns), 
moderate (white columns) and low risk organisms (grey columns) with number of persons 
working with high risk organisms (black diamonds) and moderate risk organisms (white 
squares) at least weekly for 2016 (left) and 2017 (right).
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Fig. 3. 
Equipment risks. Types of laboratory equipment assessed for relative risk for 2016 (A) and 
2017 (B) with asterisks denoting the top five perceived risks. Changes in perception (C) and 
root causes of these perception changes from 2016 (black) and 2017 (gray) (D) are shown 
with asterisks denoting the greatest change in perceived risk (C) and the primary root cause 
(D).
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Fig. 4. 
Process risks. Types of laboratory processes assessed for relative risk for 2016 (A) and 2017 
(B) with asterisks denoting the top five perceived process risks. Changes in perception (C) 
and root causes of these perception changes from 2016 (black) and 2017 (gray) (D) are 
shown with asterisks denoting the greatest change in perceived risk (C) and the primary root 
cause (D).
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Fig. 5. 
Use of risk controls. Total percent of staff that handle pathogens and report the use of risk 
controls of various types for 2016 (black) and 2017 (gray). Brackets and p-values indicate 
significant increases in self-reported use of engineering controls and eye and face PPE from 
2016 to 2017 based on a two-tailed, two sample equal variance t-test.
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Fig. 6. 
LQMS indicators. Bar graph presentation of the median response to questions about the 
frequency of work being covered by a written protocol (black), frequency of protocols being 
in a document control system (white) and frequency with which staff adhere to protocols 
(grey) for 2016 (top) and 2017 (bottom). Np statistically significant changes were observed.
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Fig. 7. 
Safety culture for reporting incidents. Responses regarding staff likeliness to report various 
events for 2016 (top) and 2017 (bottom). For each scenario, the percent of responses 
corresponding with each answer are shown. Absolutely Report (100%) (black); Most Likely 
(70–99%) (dark gray); Either Way (30–69%) (medium gray); Doubtful (1–29%) (light gray); 
and Absolutely No Report (0%) (white). Only minor injury reporting changes from 2016 to 
2017 were significant (p > 0.05) by two-tailed, two-sample equal variance t-test.
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Table 1
Internal consistency reliability (coefficient alpha).
Scale name Questions Cronbach’s alpha
Regulatory Compliance Frequency Scale Q2 0.900
Biologics Frequency Scale Q5, Q7 and Q9 0.889
Frequency of Use Scale Q13 and Q17 0.786
Frequency of Error Scale Q13 and Q17 0.875
Severity of Consequences Scale Q13 and Q17 0.778
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Table 2
Sample population demographics (n = 36).
Demographic Category Total Percent
Age Group  < 24 0 0.0%
25–34 18 51.4%
35–44 8 22.9%
45–54 6 17.1%
 > 54 3 8.6%
Highest Education Level High School 0 0.0%
Some College 0 0.0%
Associates 0 0.0%
Bachelors 8 22.2%
Masters 16 44.4%
Doctorate 12 33.3%
Management Level Supervisory 8 22.2%
Non-Supervisory 28 77.8%
Public Health Laboratory Experience  < 1 7 20.0%
1–3 8 22.9%
4–5 6 17.1%
6–10 7 20.0%
 > 10 7 20.0%
Non-Public Health Laboratory Experience  < 1 2 7.4%
1–3 6 22.2%
4–5 5 18.5%
6–10 10 37.0%
 > 10 4 14.8%
Hepatitis B Vaccination Yes 36 100.00%
No 0 0.0%
Previous Laboratory Injury Yes 8 22.9%
No 27 77.1%
Type of Public Health Experience None 9 25.0%
Federal 25 69.4%
State 2 5.6%
Local 0 0.0%
Type of Non-Public Health Laboratory Experience None 5 11.6%
Academia 20 46.5%
Clinical 9 20.9%
Private 9 20.9%
Saf Sci. Author manuscript; available in PMC 2020 August 01.
